Multicentre Evaluation of a Second Generation Point-of-Care Assay with an Extended Range for the Determination of N-Terminal Pro-Brain Natriuretic Peptide
Multicentre Evaluation of a Second Generation Point-of-Care Assay with an Extended Range for the Determination of N-Terminal Pro-Brain Natriuretic Peptide
Zugck C, Nelles M, Katus HA, et al. Multicentre evaluation of a new point-of-care test for the determination of NT-proBNP in whole blood. Clin Chem Lab Med 2006;44:1269-77. (Pubitemid 44580811)
Bertsch T, Dikkeschei B, Gurr E, et al. Development and calibretion of a new point-of-care test for the determination of NT-proBNP in whole blood. Clin Lab 2007;53:423-31. (Pubitemid 47307637)
Bertsch T, Chapelle JP, Dempfle CE, Giannitsis E, Schwab M, Zerback R. Multicentre analytical evaluation of a new point-of-care system for the determination of cardiac and thromboembolic markers. Clin Lab 2010;56:37-49.
Müller-Bardorff M, Sylvén C, Rasmanis G, et al. Evaluation of a point-of-care system for quantitative determination of troponin T and myoglobin. Clin Chem Lab Med 2000;38:567-74. (Pubitemid 30639388)
Collinson PO, Jørgensen B, Sylvén C, et al. Recalibration of the point-of-care test for Cardiac T Quantitative with Elecsys Troponin T 3rd Generation. Clin Chim Acta 2001;307:197-203. (Pubitemid 32448925)
Giannitsis E, Baum H, Bertsch T, et al. Multicentre evaluation of a new point-of-care test for the determination of CK-MB in whole blood. Clin Chem Lab Med 2008;46:630-8. (Pubitemid 351749109)
Dempfle CE, Schraml M, Besenthal I, et al. Multicenter evaluation of a new point-of-care test for the quantitative determination of D-dimer. Clin Chim Acta 2001;307:211-8. (Pubitemid 32448927)
Alehagen U, Janzon M. A clinician's experience of using the Cardiac Reader NT-proBNP point-of-care assay in a clinical setting. Eur J Heart Fail 2008;3:260-6.
Vizcaíno L, Lampón N, Marcos B, et al. Uselfulness of cobas h 232 (POCT) to measure cardiac markers in coronary emergencies. Point of Care 2008;7:211.
Zerback R, Fluder K, Schäfer M, et al. Point-of-care testing of NT-proBNP for differential diagnosis of patients presenting with dyspnea. Clin Res Cardiol 2009;98 (Suppl 2):P114.
Schäfer M, Bröker HJ, Luchner A, et al. Diagnostic equivalence of an N-terminal pro-brain natriuretic peptide point-of-care test to the laboratory method in patients with heart failure and in reference populations. Point of Care 2010; 9:91-7.
Yeo KTJ, Wu AHB, Apple FS, et al. Multicenter evaluation of the Roche NT-proBNP assay and comparison to the Biosite Triage BNP assay. Clinica Chimica Acta 2003;338:107-15. (Pubitemid 37456696)
Collinson PO, Barnes SC, Gaze DC, Galasko G, Lahiri A, Senior R. Analytical performance of the N terminal pro B type natriuretic peptide (NT-proBNP) assay on the Elecsys 1010 and 2010 analysers. Eur J Heart Fail 2004;6:365-8. (Pubitemid 38253059)
Sokoll LJ, Baum H, Collinson PO, et al. Multicenter analytical performance evaluation of the Elecsys proBNP assay. Clin Chem Lab Med 2004;42:965-72.
Fraser CG. Biological Variation: From Principles to Practice. AACC Press, Washington DC, 2001.
Wu AHB, Smith A, Wieczorek S, et al. Biological variation for N-terminal pro- and B-type natriuretic peptides and implications for therapeutic monitoring of patients with congestive heart failure. Am J Cardiol 2003;92:628-31. (Pubitemid 37013426)
Clinical and Laboratory Standards Institute. Interference Testing in Clinical Chemistry; Approved Guideline - Second Edition. CLSI document EP7-A2 [ISBN 1-56238-584-4]. Clinical and Laboratory Standards Institute, 940 West Valley Road, Suite 1400, Wayne, Pennsylvania 19087-1898 USA, 2005.
Möckel M, Müller R, Vollert JO, et al. Role of N-terminal pro-B-type natriuretic peptide in risk stratification in patients presenting in the emergency room. Clin Chem 2005;51:1624-31. (Pubitemid 41233097)
